114 related articles for article (PubMed ID: 12295559)
1. Third-generation OCs safe, health officials say.
Contracept Technol Update; 1999 Dec; 20(12):140-1. PubMed ID: 12295559
[TBL] [Abstract][Full Text] [Related]
2. Warnings on venous thromboembolism risks may have been premature. New data may lead to change in use of third-generation OCs.
Contracept Technol Update; 1997 Dec; 18(12):145-8. PubMed ID: 12348219
[TBL] [Abstract][Full Text] [Related]
3. 2 methods for prescribing third-generation OCs.
Contracept Technol Update; 1997 Dec; 18(12):148-9. PubMed ID: 12348220
[TBL] [Abstract][Full Text] [Related]
4. [Oral contraceptives: APF takes a position].
Sex Planeam Fam; 1995; (7):17-8. PubMed ID: 12179267
[TBL] [Abstract][Full Text] [Related]
5. Venous thromboembolism and desogestrel- or gestodene-containing combination oral contraceptives: what are the facts?
Contracept Rep; 1996 Apr; 7(1):3-6. PubMed ID: 12320047
[TBL] [Abstract][Full Text] [Related]
6. Another pill scare -- should we audit its impact?
Bromham DR
Audit Unit News; 1996 Jan; 1(4):2-3. PubMed ID: 12346948
[TBL] [Abstract][Full Text] [Related]
7. Pill research results in new guidance from CSM.
Fam Plann Today; 1995; ():1. PubMed ID: 12319465
[TBL] [Abstract][Full Text] [Related]
8. Don't be scared.
Killick S
Audit Unit News; 1996 Jan; 1(4):1. PubMed ID: 12346947
[TBL] [Abstract][Full Text] [Related]
9. Rebuilding confidence in oral contraceptives: a new imperative in family planning.
Spitzer WO
Br J Clin Pharmacol; 1996 May; 41(5):359-63. PubMed ID: 8735675
[TBL] [Abstract][Full Text] [Related]
10. Oral contraceptive pills and the risk of venous thromboembolism.
Prog Hum Reprod Res; 1996; (39):2-3. PubMed ID: 12292198
[TBL] [Abstract][Full Text] [Related]
11. German court lifts OC prescription ban.
Contracept Technol Update; 1998 Mar; 19(3):41-2. PubMed ID: 12293274
[TBL] [Abstract][Full Text] [Related]
12. Effect of the British warning on contraceptive use in the General Medical Service in Ireland.
Williams D; Kelly A; Carvalho M; Feely J
Ir Med J; 1998 Dec; 91(6):202-3. PubMed ID: 10069128
[TBL] [Abstract][Full Text] [Related]
13. Estrogen dose in oral contraceptives: FDA committee examines safety and utility of 50 mcg estrogen OCs.
Contracept Rep; 1994 Mar; 5(1):10-3. PubMed ID: 12287738
[TBL] [Abstract][Full Text] [Related]
14. Effect of 1995 pill scare on rates of venous thromboembolism among women taking combined oral contraceptives: analysis of general practice research database.
Farmer RD; Williams TJ; Simpson EL; Nightingale AL
BMJ; 2000 Aug 19-26; 321(7259):477-9. PubMed ID: 10948026
[TBL] [Abstract][Full Text] [Related]
15. Oral contraceptives and venous thromboembolism: consensus conference statement.
Dialogues in Contraception Consensus Conference (1995: Chicago)
Dialogues Contracept; 1996; ():1-8. PubMed ID: 12320455
[TBL] [Abstract][Full Text] [Related]
16. The risk of venous thromboembolism in users of postcoital contraceptive pills.
Vasilakis C; Jick SS; Jick H
Contraception; 1999 Feb; 59(2):79-83. PubMed ID: 10361621
[TBL] [Abstract][Full Text] [Related]
17. Impact of the October 1995 pill scare in Grampian.
Flett G; Gurney E; McKessock L; Reid J
Br J Fam Plann; 1998 Apr; 24(1):18-20. PubMed ID: 9719702
[TBL] [Abstract][Full Text] [Related]
18. Oral contraceptive mortality.
Kestleman P
IPPF Eur Reg Inf; 1978 Jan; 7(1):5-7. PubMed ID: 12178332
[TBL] [Abstract][Full Text] [Related]
19. Combined oral contraception and the risk of venous thromboembolism.
Mills A
Hum Reprod; 1997 Dec; 12(12):2595-8. PubMed ID: 9455819
[TBL] [Abstract][Full Text] [Related]
20. The case for a lower dose pill. Assessing the impact of estrogen dose.
Brown S; Cropfield O
ORGYN; 1995; (2):36-9. PubMed ID: 12319251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
